Controversies surrounding the administration of vitamin K to newborns: A review

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 3, 1996, Pages 307-315

  Brousson, Michelle A ^b   Klein, Michael C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP;

ARTICLE; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG SAFETY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; META ANALYSIS; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; ORAL DRUG ADMINISTRATION; RISK; VITAMIN K DEFICIENCY;

EID: 0030022390     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Golding J, Paterson M, Kinlen LJ: Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990; 62: 304-308
2. Golding J, Greenwood R, Birmingham K et al: Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305: 341-346
3. Draper G, McNinch A: Vitamin K for neonates: the controversy. BMJ 1994; 308: 867-868
4. Rennie JM, Kelsall AWR: Vitamin K prophylaxis in the newborn - again. Arch Dis Child 1994; 70: 248-251
5. Townsend CW: The hemorrhagic disease of the newborn. Arch Paediatr 1894; 11: 559-565
6. Committee on Nutrition, American Academy of Pediatrics: Vitamin K compounds and the water-soluble analogues: use in therapy and prophylaxis in pediatrics. Pediatrics 1961; 28: 501-507
7. Von Kries R, Shearer MJ, Gobel U: Vitamin K in infancy. [review] Eur J Pediatr 1988; 147: 106-112
8. McNinch AW, Orme RL, Tripp JH: Hemorrhagic disease of the newborn returns. Lancet 1983; 1: 1089-1090
9. Lane PA, Hathaway WE: Medical progess: vitamin K in infancy. J Pediatr 1985; 106: 351-359
10. Von Kries R: Vitamin K prophylaxis - A useful public health measure? [review] Paediatr Perinat Epidemiol 1992; 6: 7-13
11. McNinch VW, Tripp JH: Hemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991; 303: 1105-1109
12. Greer FR, Marshall S, Cherr J et al: Vitamin K status of lactating mother, human milk, and breast-feeding infants. Pediatrics 1991; 88: 751-755
13. Tripp JH, McNinch AW: Hemorrhagic disease and vitamin K. Arch Dis Child 1987; 67: 436-437
14. Handel J, Tripp I: Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom. BMJ 1991; 303: 1109
15. Croucher C, Azzopardi D: Compliance with recommendations for giving vitamin K to newborn infants. BMJ 1994; 308: 894-895
16. Von Kries R, Gobel U: Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn. Lancet 1994; 343: 352
17. Vitamin K Ad Hoc Task Force, American Academy of Pediatrics: Controversies concerning vitamin K and the newborn. Pediatrics 1993; 91: 1001-1003
18. Fetus and Newborn Committee, Canadian Paediatric Society: The use of vitamin K in the perinatal period. Can Med Assoc J 1988; 139: 127-130
19. 1 [news bulletin], Canadian Paediatric Society, Ottawa, 1993
20. Malhotra KK: Care of the newborn in perinatal units in New Brunswick. Can Med Assoc J 1986; 134: 1009-1011
21. Loughnan PM, McDougall PN: Epidemiology of late onset haemorrhagic disease: a pooled data analysis. J Paediatr Child Health 1993; 29: 177-181
22. Von Kries R, Gobel U: Vitamin K prophylaxis and vitamin K deficiency bleeding in early infancy. Acta Paediatr 1992; 81: 655-657
23. Carmichael A: Vitamin K administration to the newborn: a public health policy and service delivery dilemma. J Paediatr Child Health 1993; 29: 167-168
24. Hathaway WE, Isarangkura PB, Mahasandana C et al: Comparison of oral and parenteral vitamin K prophylaxis for the prevention of late hemorrhagic disease of the newborn. J Pediatr 1991; 119: 461-464
25. Hogenbirk K, Peters M, Bournan P et al: The effect of formula versus breast feeding and exogenous vitamin K-dependent clotting factors in newborns. Eur J Pediatr 1993; 52: 72-74
26. Motohara K, Endo F, Matsuda I: Vitamin K defiency in breast-fed infants at one month of age. J Pediatr Gastroenterol Nutr 1986; 5: 931-933
27. 1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child 1992; 67: 1250-1254
28. 1 to prevent vitamin K deficiency in breast-fed infants. J Pediatr Gastroenterol Nutr 1993; 16: 301-305
29. Cornelissen EA, Kollee LA, De Abreu RA et al: Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr 1993; 82: 656-659
30. Von Kries R: Neonatal vitamin K: prophylaxis for all. BMJ 1991; 303: 1083-1084
31. Shearer MJ, Mallinson CN, Webster CR et al: Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K in man. Br J Haematol 1972; 22: 579-588
32. Carstensen J: Intramuscular vitamin K and childhood cancer. [letter] BMJ 1992; 305: 709-710
33. Klebanoff M, Read J, Mills J et al: The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med 1993; 329: 905-908
34. Ekelund H, Finnstrom O, Gunnarskog J et al: Administration of vitamin K to newborn infants and childhood cancer. BMJ 1993; 307: 89-91
35. Olsen JH, Hertz H, Blinkenberg K et al: Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ 1994; 308: 895-896
36. Sann L, Lecierc M, Guillaumont M: Vitamin K in infancy. Eur J Pediatr 1988; 143: 1-3
37. Dunn HP: Vitamin K for all newborn babies. BMJ 1992; 305: 710
38. 1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone. J Pediatr Gastroenterol Nutr 1993; 16: 435-439
39. National Research Council Food and Nutrition Board: Fat-soluble vitamins. In Recommended Dietary Allowances, 10 ed, National Academy Press, Washington, 1989: 78-114
40. 1 in neonates. Arch Dis Child 1985; 60: 814-818
41. Tulchinsky TH, Patton MS, Randolph LA et al: Mandating vitamin K prophylaxis for newborns in New York State. Am J Public Health 1993; 83: 1166-1167